BEAM
Price
$32.40
Change
+$3.79 (+13.25%)
Updated
Feb 14 closing price
Capitalization
2.68B
17 days until earnings call
MNKD
Price
$5.42
Change
-$0.13 (-2.34%)
Updated
Feb 14 closing price
Capitalization
1.49B
17 days until earnings call
Ad is loading...

BEAM vs MNKD

Header iconBEAM vs MNKD Comparison
Open Charts BEAM vs MNKDBanner chart's image
Beam Therapeutics
Price$32.40
Change+$3.79 (+13.25%)
Volume$3.37M
Capitalization2.68B
MannKind
Price$5.42
Change-$0.13 (-2.34%)
Volume$2.27M
Capitalization1.49B
BEAM vs MNKD Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. MNKD commentary
Feb 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and MNKD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Feb 15, 2025
Stock price -- (BEAM: $32.40 vs. MNKD: $5.42)
Brand notoriety: BEAM and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 284% vs. MNKD: 95%
Market capitalization -- BEAM: $2.68B vs. MNKD: $1.49B
BEAM [@Biotechnology] is valued at $2.68B. MNKD’s [@Biotechnology] market capitalization is $1.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $350B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileMNKD’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • MNKD’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than MNKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while MNKD’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • MNKD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than MNKD.

Price Growth

BEAM (@Biotechnology) experienced а +18.21% price change this week, while MNKD (@Biotechnology) price change was -3.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.27%, and the average quarterly price growth was +6.50%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

MNKD is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.68B) has a higher market cap than MNKD($1.5B). BEAM YTD gains are higher at: 30.645 vs. MNKD (-15.708). MNKD has higher annual earnings (EBITDA): 68.8M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. MNKD (252M). BEAM has less debt than MNKD: BEAM (162M) vs MNKD (240M). BEAM has higher revenues than MNKD: BEAM (350M) vs MNKD (267M).
BEAMMNKDBEAM / MNKD
Capitalization2.68B1.5B179%
EBITDA-160.83M68.8M-234%
Gain YTD30.645-15.708-195%
P/E RatioN/A67.75-
Revenue350M267M131%
Total Cash926M252M367%
Total Debt162M240M68%
FUNDAMENTALS RATINGS
MNKD: Fundamental Ratings
MNKD
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMNKD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRKUX14.370.10
+0.70%
MFS Blended Research Em Mkts Eq R4
SEEIX12.11N/A
N/A
SEI International Equity I (SIT)
HULIX33.89N/A
N/A
Huber Select Large Cap Value Inv
VHYAX40.41N/A
N/A
Vanguard High Dividend Yield Index Adm
AVUVX17.30N/A
N/A
Avantis® U.S. Small Cap Value Instl

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-2.34%
VCYT - MNKD
44%
Loosely correlated
+3.84%
LXRX - MNKD
42%
Loosely correlated
+5.88%
INSM - MNKD
40%
Loosely correlated
+0.81%
BLUE - MNKD
38%
Loosely correlated
+0.28%
AMRN - MNKD
36%
Loosely correlated
+1.16%
More